News
DNPUF
11.60
NaN%
--
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
TipRanks · 03/25 07:02
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
TipRanks · 03/06 00:22
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
TipRanks · 03/02 06:57
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
TipRanks · 03/02 06:57
Sumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
TipRanks · 03/02 06:57
Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment
Seeking Alpha · 02/20 11:20
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
TipRanks · 01/30 07:13
Sumitomo Pharma Outlines Q3 FY2025 Results With Caution on Forward-Looking Data
TipRanks · 01/30 07:13
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 12/16/2025 12:16
Sumitomo Pharma Reports Strong Half-Year Results and Raises Full-Year Forecasts
TipRanks · 10/31/2025 07:12
Sumitomo Pharma Completes Strategic Sale in Asian Business Restructuring
TipRanks · 10/31/2025 07:12
Trump’s 100% drug tariffs send pharma stocks lower
Seeking Alpha · 09/26/2025 08:59
Weekly Report: what happened at DNPUF last week (0908-0912)?
Weekly Report · 09/15/2025 10:56
Sumitomo Dainippon Pharma Co (DNPUF) Gets a Buy from Jefferies
TipRanks · 09/08/2025 17:55
Weekly Report: what happened at DNPUF last week (0901-0905)?
Weekly Report · 09/08/2025 10:58
J.P. Morgan Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 09/05/2025 14:25
Weekly Report: what happened at DNPUF last week (0825-0829)?
Weekly Report · 09/01/2025 10:54
Weekly Report: what happened at DNPUF last week (0818-0822)?
Weekly Report · 08/25/2025 11:03
Citi Sticks to Its Sell Rating for Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 08/22/2025 11:25
Sumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
TipRanks · 08/22/2025 11:00
More
Webull provides a variety of real-time DNPUF stock news. You can receive the latest news about DAI Nippon Pharm through multiple platforms. This information may help you make smarter investment decisions.
About DNPUF
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.